Delpha Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,106
Closed -$44K 375
2017
Q4
$44K Buy
+2,106
New +$44K 0.05% 363